FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

704256006: Vedolizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3011048012 Vedolizumab en Synonym Active Entire term case insensitive SNOMED CT core module
3011945013 Vedolizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vedolizumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Vedolizumab Is a Substance with alpha-4 integrin receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Vedolizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Vedolizumab Has disposition Alpha-4 integrin receptor antagonist true Inferred relationship Existential restriction modifier
Vedolizumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Vedolizumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Vedolizumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Vedolizumab Inferred relationship Existential restriction modifier
Product containing vedolizumab Has active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Vedolizumab Has active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Vedolizumab therapy Direct substance True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing vedolizumab in parenteral dose form (medicinal product form) Has active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing only vedolizumab in parenteral dose form (medicinal product form) Has active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 158.824 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 158.824 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Vedolizumab Inferred relationship Existential restriction modifier 1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Vedolizumab Inferred relationship Existential restriction modifier 1
Mass concentration of vedolizamab in serum (observable entity) Component True Vedolizumab Inferred relationship Existential restriction modifier 1
Vedolizumab 300mg powder for solution for infusion vials Has active ingredient False Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled syringes Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices Has active ingredient False Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled syringes Has active ingredient False Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 108mg/0.68ml solution for injection pre-filled syringes (Takeda UK Ltd) 2 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 108mg/0.68ml solution for injection pre-filled syringes (Takeda UK Ltd) Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 108mg/0.68ml solution for injection pre-filled pens (Takeda UK Ltd) 2 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 108mg/0.68ml solution for injection pre-filled syringes (Takeda UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 108mg/0.68ml solution for injection pre-filled pens (Takeda UK Ltd) Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 108mg/0.68ml solution for injection pre-filled pens (Takeda UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 300mg powder for concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 300mg powder for concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 300mg powder for solution for infusion vials Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 300mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Vedolizumab 300mg powder for solution for infusion vials 1 vial Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier
Entyvio 300mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) 1 vial Has specific active ingredient True Vedolizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start